AI-generated summary
The authors reviewed clinical trials from 2018 to 2022 on lasers for atrophic facial acne scars, summarized in narrative form. They report that improvement was seen across a variety of lasers, with ablative lasers giving the most significant improvement but longer downtime than nonablative lasers. Laser choice was described as individualized and based on shared decision-making.
- Who or what was studied
- Patients with atrophic facial acne scars in clinical trials
- Limits stated in the abstract
- The review is a narrative summary of trials identified through a single PubMed search, and the abstract does not report a count of included studies or participants.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on jddonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Laser, Digital object identifier. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.